Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc.

NUSNYSE / NASDAQConsumer DefensiveSmall cap

$3.80+$0.03 (+0.8%)

Last close · Data as of Nov 20, 2026

Market cap
$258.3M
P/E
1.6x
EV / EBITDA
1.2x
Revenue
$1.5B
Net margin
10.8%
ROCE
20.4%

-59.9% over the last year

Nu Skin Enterprises, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-23.7%
3M
-18.3%
6M
-34.9%
1Y
-59.9%
5Y
-91.9%

52-week range

Day change +$0.03 (+0.8%) from $3.77 to $3.80 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in NUS, bought on each weekday since 2021.

News & filings

What Nu Skin Enterprises filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthReturn on equity rose from -22.5% to 19.9% between fiscal 2024 and fiscal 2025.

Concerns (1)

  • The price is 35.5% below its 200-day average, and the 50-day average is below the 200-day.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.

Read moreShow less

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Sector
Consumer Defensive
Shares outstanding
48.2M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$258.3M
P/E
1.6x
P/B
0.3x
EV / EBITDA
1.2x
EV / Sales
0.2x
P/S
0.2x
52-week high
$11.54
52-week low
$3.77

Profitability

Operating margin
6.1%
Net margin
10.8%
EBITDA margin
17.7%
ROE
19.9%
ROCE
20.4%
ROIC
19.7%
ROA
11.4%
Asset turnover
1.06

Growth

Revenue
$1.5B
Revenue growth, 1Y
-14.3%
Revenue CAGR, 3Y
-12.6%
Net profit growth, 1Y
-209.3%
Free cash flow
$46.0M

Solvency

Current ratio
2.08
Debt / Equity
0.38
Debt / Assets
0.22
CFO / Net profit
0.50
Cash / Market cap
92.9%

Where the revenue went

Of every $100 of FY2025 revenue, $11 was left as net income.

Nu Skin Enterprises, Inc. income statement flow, FY2025
Nu Skin Enterprises, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$453.8M
RevenueGross profit$1.0B
Gross profitSelling, general and administrative$940.5M
Gross profitOther operating expenses$0.00
Gross profitOperating income$90.9M
Operating incomePretax income$90.9M
Interest and other incomePretax income$105.3M
Pretax incomeTax and other$36.0M
Pretax incomeNet income$160.2M

Revenue and net profit

Revenue fell 14.3% in FY2025; net profit is the dashed line.

Nu Skin Enterprises, Inc. revenue and net profit by fiscal year
Nu Skin Enterprises, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$2.2B$104.8M
FY2023$2.0B$8.6M
FY2024$1.7B-$146.6M
FY2025$1.5B$160.2M

Cash flows

FY2025: $80.3M from operations, $46.0M free after investment (dashed).

Nu Skin Enterprises, Inc. operating and free cash flow by fiscal year
Nu Skin Enterprises, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$108.1M$49.0M
FY2023$118.6M$60.1M
FY2024$111.7M$70.2M
FY2025$80.3M$46.0M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$1.5B-14.3%1Y
EBITDA
$262.4M
Net profit
$160.2M
Cash from operations
$80.3M-28.2%1Y
Free cash flow
$46.0M-34.4%1Y
Revenue CAGR, 3Y
-12.6%
Net profit CAGR, 3Y
15.2%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$1.5B$262.4M$160.2M$46.0M19.9%-14.3%-209.3%

Monthly returns

Month-by-month returns of NUS across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$1.4B
Liabilities$600.1M
Equity$805.2M
Paid-in capital$636.0M
Retained earnings$1.9B
Treasury stock$1.6B

Market cap against peers

8 peers: same sector, nearest by size.

  1. Nu Skin Enterprises, Inc. (this company)$258.3M

Peers map

Consumer Defensive companies placed by value, growth and quality; NUS highlighted.

P/E against peers

NUS trades at 1.6x earnings against a peer median of 14.5x (a 89% discount).

  1. Nu Skin Enterprises, Inc. (this company)1.6x

EV / Sales, for the companies without earnings

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Nu Skin Enterprises, Inc.NUSthis companyP/E ↓ discount$258.3M1.6x0.3x19.9%1.2x
USANA Health Sciences, Inc.USNA$334.7M31.1x0.6x2.0%2.4x
B&G Foods, Inc.BGS$320.6M—0.7x-9.6%12.0x
European Wax Center, Inc.EWCZ$319.1M36.8x4.0x11.0%9.9x
Alico, Inc.ALCO$299.8M-2.0x2.9x-143.0%-78.1x
Franklin Covey Co.FC$269.7M87.9x4.0x4.6%15.2x
Forafric Global PLCAFRI$268.3M-18.0x-30.9x171.4%40.6x
Waldencast plcWALD$224.5M—0.4x-49.7%—
Limoneira CompanyLMNR$214.9M-13.4x1.3x-9.9%-28.0x
Peer median—14.5x1.0x-3.8%9.9x

Year-to-date ROI

NUS since 1 January, against earlier years.

Historical volatility

NUS's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Nu Skin Enterprises, Inc. operating margin by fiscal year
Nu Skin Enterprises, Inc. operating margin by fiscal year
DateOperating margin
FY20227.2%
FY20233.5%
FY20242.9%
FY20256.1%
LineFY2025
Cost of revenueCost Of Revenue$453.8M
Gross profitGross Profit$1.0B
Operating expensesOperating Expense$940.5M
Total expensesTotal Expenses$1.4B
Pretax incomePretax Income$196.2M

Learn while you research

Academy chapters picked for Nu Skin Enterprises, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Value InvestingA P/E of 1.6 could be a value opportunity, or a value trap. Know the difference.7 min read
  3. 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  4. 04 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →